Performance evaluation of the ADVIA Centaur® HIV Ag/Ab Combo assay

Journal of Virological Methods

Volumn 170, Issue 1-2, 2010, Pages 16-20

  Pumarola, Tomàs ^a   Freeman, James ^b   Saxton, Emeline ^b   Dillon, Paul ^b   Bal, Tricia ^c   van Helden, Josef ^d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Siemens Healthcare Diagnostics Inc   (United States)

^c Siemens Healthcare Diagnostics Inc   (United States)

^d NONE   (Germany)

Author keywords

ADVIA Centaur; Diagnosis; HIV; Immunoassay; Sensitivity; Specificity

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ARTICLE; AUTOANALYSIS; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; EARLY DIAGNOSIS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROCONVERSION;

AIDS SERODIAGNOSIS; EARLY DIAGNOSIS; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HIV-2; HUMANS; IMMUNOASSAY; MASS SCREENING; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 78249248680     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2010.08.012     Document Type: Article

References (9)

1. Branson B.M., Handsfield H.H., Lampe M.A., Janssen R.S., Taylor A.W., Lyss S.B., Clark J.E. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm. Rep. 2006, 22:1-17.
2. Busch M.P., Satten G.A. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. Am. J. Med. 1997, 102:117-124.
3. Gaudy C., Moreau A., Brunet S., Descamps J.M., Deleplanque P., Brand D., Barin F. Subtype B human immunodeficiency virus (HIV) type 1 mutant that escapes detection in a fourth-generation immunoassay for HIV infection. J. Clin. Microbiol. 2004, 42:2847-2849.
4. Hoffman C.J., Gallant J.E. HIV and AIDS. ACP Medicine 2007, 1-32. American College of Physicians and BC Decker Inc., Ontario. E.G. Nabel, D.D. Federman (Eds.).
5. Kopko P.M., Fernando L.P., Bonney E.N., Freeman J.L., Holland P.V. HIV transmissions from a window-period platelet donation. Am. J. Clin. Pathol. 2001, 116:562-566.
6. Liikanen E. Commission decision of 7 May 2002 on common technical specifications for in vitro diagnostic medical devices. Off. J. Eur. Commun. 2002, L131:17-30.
7. Ly T.D., Martin L., Daghfal D., Sandridge A., West D., Bristow R., Chalouas L., Qiu X., Lou S.C., Hunt J.C., Schochetman G., Devare S.G. Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection. J. Clin. Microbiol. 2001, 39:3122-3128.
8. Skidmore S., Devendra S., Weaver J., Short J., Osman H., Smit E. A case study of delayed HIV-1 seroconversion highlights the need for combo assays. Int J. STD AIDS 2009, 20:205-206.
9. World Health Organization and UNAIDS HIV/AIDS Programme Strengthening Health Services to Fight HIV/AIDS. Guidance on Provider-Initiated HIV Testing and Counseling in Health Facilities 2007, World Health Organization, Geneva.